维普中文期刊产品整合服务
92篇 您的检索式:作者名="ROMI F"
    题名 作者 年代 出处 被引量
1The Severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies 显示文摘Romi F Skeie GO Aarli JA 2000Arch Neurol2000,57,11:1
2Serum levels of matrix metalloproteinases: implications in clinical neurology显示文摘Romi F Helgeland G Gilhus NE 2012Eur Neurol2012,67,2:1
3Striational antibodies in myasthenia gravis: reactivity and possible clinical significance显示文摘Romi F Skeie G O Gilhus N E 2005Arch Neurol2005,62,3:1
4Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis显示文摘Romi F Gilhus NE Varhaug JE 2002Eur J Neuol2002,9,1:1
5Myasthenia gravis in individuals over 40显示文摘Aarli J A Romi F Skeie G O 2003Ann NY Acad Sci2003,998,:1
6Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features显示文摘Romi F Aarli J A Gilhus N E 2007Eur J Neurol2007,14,6:1
7Muscle autoantibodies in subgroups of myasthenia gravis patients显示文摘Romi F Skeie GO Aarli JA 2000J Neurol2000,247,5:1
8Complement activation by titin and ryanodine receptor autoantibcdies in myasthenia gravis, a study of lgG subclasses and clinical correlations显示文摘Romi F Skeie GO Vedeler C 2000J Neuroimmunol2000,111,12:1
9Myasthenia gravis: disease severity and prognosis显示文摘Romi F Gilhus NE Aarli JA 2006Acta Neurol Scand Suppl2006,183,:1
10Muscle autoanitibodies in subgroups of MG patients显示文摘Romi F Skeie GO Aarli JA 2000J Neurol2000,247,1:1
11Muscle autoantibodies in subgroups of myasthenia gravis patients显示文摘Romi F Skeie GO Aarli JA eta.l 0,,05:1
12Myasthenia gravis:clinical,immunolog-ical,and therapeutic advances显示文摘Romi F Gilhus NE Aarli JA 2005Acta Neurol Scand2005,111,2:1
13Endotoxin removal from solutions of F(ab) 2 fragments of equine antibodies against snake venom using macroporous chitosan membrane显示文摘 Romi Lamb M Eduardo Josde A etal 2004Journal of Membrane Science2004,234,:1
14Seronegative myasthenia gravis: disease severity and prognosis 显示文摘Romi F Aarili JA Gilhus NE 2006Acta Neurol Scand Suppl2006,183,44:1
15Thymoma in myasthenia gravis:from diagnosis to treatment显示文摘Romi F 0,,:1
16Complement activation by titin and rganodine receptor autoantibodies in myasthenia gravis,a study of IgG subclasses and clinical correlations显示文摘Romi F Skeie GO Vedeler C 2000J Neuroimmunol2000,111,:1
17Muscle autoantibodies in subgroups of myasthenia gravis patients显示文摘Romi F Skeie GO Aarli JA 2000J Neurol2000,247,5:1
18Seronegative myasthenia gra vis: disease severity and prognosis显示文摘Romi F Aarli J A Gilhus NE 2005Eur J Neurol2005,12,41:1
19Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls显示文摘Luckman SP Gilhus NE Romi F 2011Autoimrnune Dis2011,8,15:1
20The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies显示文摘Romi F skeie GO Aarli JA 2000Arch Neurol2000,57,11:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费